Delivery Order SPE2DB20D1004-SPE2DB20FE8T7
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $2,099.76 Firm Fixed Price delivery order is for a Prime Vendor Pharmaceutical Branch-Philadelphia, with an ultimate completion date of December 1, 2020. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,089.55 delivery order was issued by the Defense Logistics Agency (DLA) for the "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" requirement. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 26, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for pharmaceutical and medical supply distribution services. The $10,369.01 delivery order contract is a firm fixed-price agreement for the Prime Vendor Pharmaceutical Branch in Philadelphia. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order worth $1,311.38 for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" from the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $2,163.84 delivery order is for a Prime Vendor Pharmaceutical Branch-Philadelphia and has a completion date of June 15, 2021. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,854.80 delivery order contract is for the Prime Vendor Pharmaceutical Branch in Philadelphia, with a completion date of September 2, 2020. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for a Prime Vendor Pharmaceutical contract. The delivery order, valued at $1,443.36, provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $50,327.73 for pharmaceutical and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) for the Prime Vendor Pharmaceutical Branch in Philadelphia. The contract is a Firm Fixed Price Delivery Order that does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award from the Defense Logistics Agency (DLA) is for a Prime Vendor Pharmaceutical Branch-Philadelphia delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,401.60 fixed-price contract provides a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities and veteran healthcare programs....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,547.32 firm-fixed-price delivery order is for a Prime Vendor Pharmaceutical Branch in Philadelphia and has a completion date of November 27, 2020. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB20FE8T7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $1,739.91 delivery order is for a "Prime Vendor Pharm Branch-Philadelphia" requirement and has an ultimate completion date of July 27, 2020. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits, to support military treatment facilities and Department of Veterans Affairs healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/24/20 |